Literature DB >> 12406535

Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).

B Bencherif1, P N Fuchs, R Sheth, R F Dannals, J N Campbell, J J Frost.   

Abstract

The role of the supraspinal endogenous opioid system in pain processing has been investigated in this study using positron emission tomography imaging of [11C]-carfentanil, a synthetic, highly specific mu opioid receptor (mu-OR) agonist. Eight healthy volunteers were studied during a baseline imaging session and during a session in which subjects experienced pain induced by applying capsaicin topically to the dorsal aspect of the left hand. A pain-related decrease in brain mu-OR binding was observed in the contralateral thalamus consistent with competitive binding between [11C]-carfentanil and acutely released endogenous opioid peptides. This decrease varied directly with ratings of pain intensity. These results suggest that the supraspinal mu-opioid system is activated by acute pain and thus may play a substantial role in pain processing and modulation in pain syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406535     DOI: 10.1016/S0304-3959(02)00266-X

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  32 in total

1.  Alterations in endogenous opioid functional measures in chronic back pain.

Authors:  Ilkka K Martikainen; Marta Peciña; Tiffany M Love; Emily B Nuechterlein; Chelsea M Cummiford; Carmen R Green; Richard E Harris; Christian S Stohler; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

3.  Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A.

Authors:  Talakad G Lohith; Sami S Zoghbi; Cheryl L Morse; Maria F Araneta; Vanessa N Barth; Nancy A Goebl; Johannes T Tauscher; Victor W Pike; Robert B Innis; Masahiro Fujita
Journal:  J Nucl Med       Date:  2012-02-06       Impact factor: 10.057

4.  Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.

Authors:  Lauri Tuominen; Lauri Nummenmaa; Liisa Keltikangas-Järvinen; Olli Raitakari; Jarmo Hietala
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

5.  Self-reported sleep duration associated with distraction analgesia, hyperemia, and secondary hyperalgesia in the heat-capsaicin nociceptive model.

Authors:  Claudia M Campbell; Sara C Bounds; Mpepera B Simango; Kenneth R Witmer; James N Campbell; Robert R Edwards; Jennifer A Haythornthwaite; Michael T Smith
Journal:  Eur J Pain       Date:  2010-12-30       Impact factor: 3.931

6.  Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.

Authors:  Jussi Lehto; Jarkko Johansson; Lauri Vuorilehto; Pauliina Luoto; Eveliina Arponen; Harry Scheinin; Juha Rouru; Mika Scheinin
Journal:  Psychopharmacology (Berl)       Date:  2015-04-29       Impact factor: 4.530

7.  A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia.

Authors:  Darin D Dougherty; Jian Kong; Megan Webb; Ali A Bonab; Alan J Fischman; Randy L Gollub
Journal:  Behav Brain Res       Date:  2008-05-02       Impact factor: 3.332

Review 8.  The association of sleep and pain: an update and a path forward.

Authors:  Patrick H Finan; Burel R Goodin; Michael T Smith
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

9.  Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain.

Authors:  Claudia M Campbell; Robert R Edwards; Cheryl Carmona; Magdalena Uhart; Gary Wand; Alene Carteret; Yu Kyeong Kim; James Frost; James N Campbell
Journal:  Pain       Date:  2008-12-09       Impact factor: 6.961

Review 10.  Tobacco/nicotine and endogenous brain opioids.

Authors:  Yue Xue; Edward F Domino
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-12-23       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.